CA2361572A1 - Prevention de la formation d'abces - Google Patents
Prevention de la formation d'abces Download PDFInfo
- Publication number
- CA2361572A1 CA2361572A1 CA002361572A CA2361572A CA2361572A1 CA 2361572 A1 CA2361572 A1 CA 2361572A1 CA 002361572 A CA002361572 A CA 002361572A CA 2361572 A CA2361572 A CA 2361572A CA 2361572 A1 CA2361572 A1 CA 2361572A1
- Authority
- CA
- Canada
- Prior art keywords
- solution
- hyaluronic acid
- surgery
- surgical procedure
- tissue
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/716—Glucans
- A61K31/717—Celluloses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Apparatus For Disinfection Or Sterilisation (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
- External Artificial Organs (AREA)
Abstract
L'invention concerne un procédé relatif à la prévention ou à la réduction de la gravité de la formation d'un abcès chez l'homme, qui consiste à utiliser une solution diluée de polysaccharide polyanionique, et de préférence une solution d'acide hyaluronique ou de carboxyméthylcellulose, en application au tissu sur le site d'une procédure chirurgicale.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11870799P | 1999-02-04 | 1999-02-04 | |
US60/118,707 | 1999-02-04 | ||
PCT/US2000/002988 WO2000045804A2 (fr) | 1999-02-04 | 2000-02-04 | Prevention de la formation d'abces |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2361572A1 true CA2361572A1 (fr) | 2000-08-10 |
Family
ID=22380260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002361572A Abandoned CA2361572A1 (fr) | 1999-02-04 | 2000-02-04 | Prevention de la formation d'abces |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1148886A2 (fr) |
JP (1) | JP2002536323A (fr) |
AU (1) | AU3356600A (fr) |
CA (1) | CA2361572A1 (fr) |
WO (1) | WO2000045804A2 (fr) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2002154906A (ja) * | 2000-11-13 | 2002-05-28 | Michio Hayashi | 抗菌剤組成物 |
US7700819B2 (en) | 2001-02-16 | 2010-04-20 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7763769B2 (en) | 2001-02-16 | 2010-07-27 | Kci Licensing, Inc. | Biocompatible wound dressing |
US7238677B2 (en) | 2003-03-28 | 2007-07-03 | Kimberly-Clark Worldwide, Inc. | Prevention of urogenital infections |
EP1911769B1 (fr) * | 2005-08-04 | 2013-10-30 | Teijin Limited | Dérivé de cellulose |
RU2486892C1 (ru) * | 2011-11-25 | 2013-07-10 | Федеральное государственное бюджетное образовательное учреждение высшего профессионального обучения "Хакасский государственный университет им. Н.Ф. Катанова" (ФГБОУ ВПО "ХГУ им. Н.Ф.Катанова") | Способ лимфотропной терапии при ортодентальных абсцессах у кроликов |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1340994C (fr) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Traitement de maladies et d'etats pathologiques |
US5700787A (en) * | 1994-09-02 | 1997-12-23 | Brigham & Women's Hospital, Inc. | Capsular polysaccharide immunomodulator |
JPH09208476A (ja) * | 1996-01-26 | 1997-08-12 | Takada Seiyaku Kk | 腹腔内投与用医薬組成物 |
-
2000
- 2000-02-04 AU AU33566/00A patent/AU3356600A/en not_active Abandoned
- 2000-02-04 JP JP2000596924A patent/JP2002536323A/ja active Pending
- 2000-02-04 CA CA002361572A patent/CA2361572A1/fr not_active Abandoned
- 2000-02-04 WO PCT/US2000/002988 patent/WO2000045804A2/fr not_active Application Discontinuation
- 2000-02-04 EP EP00911708A patent/EP1148886A2/fr not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
EP1148886A2 (fr) | 2001-10-31 |
AU3356600A (en) | 2000-08-25 |
WO2000045804A3 (fr) | 2001-03-08 |
JP2002536323A (ja) | 2002-10-29 |
WO2000045804A2 (fr) | 2000-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Burns et al. | A hyaluronate based gel for the prevention of postsurgical adhesions: evaluation in two animal species | |
US11000574B2 (en) | Hyaluronic acid containing compositions for prevention of the formation of post-surgical scars and post-surgical adhesions | |
Back et al. | Application of hyaluronic acid/sodium alginate-based microparticles to prevent tissue adhesion in a rabbit model | |
Cheung et al. | Adjuvant therapy for the reduction of postoperative intra-abdominal adhesion formation | |
Murphy et al. | Use of a high-molecular-weight carboxymethylcellulose in a tissue protective solution for prevention of postoperative abdominal adhesions in ponies | |
DK175597B1 (da) | Anvendelse af en vævsplasminogenaktivator (t-PA) til fremstilling af et præparat til anvendelse til forebyggelse af fibrinaflejring eller adhærencedannelse eller -gendannelse, topiske præparater og dispenseringsindretninger til. | |
CA2361572A1 (fr) | Prevention de la formation d'abces | |
Peck et al. | Topics and trends in surgical research: evaluation of CMC and HA solutions for adhesiolysis | |
Reijnen et al. | Hyaluronic acid‐based agents do not affect anastomotic strength in the rat colon, in either the presence or absence of bacterial peritonitis | |
US8158610B2 (en) | Dextrin-containing composition for preventing surgical adhesions | |
JP4276601B2 (ja) | 外科手術上の癒着を阻止するためのデキストリンを含有する組成物 | |
EP1001790B1 (fr) | Composition destinee a la lubrification et a la separation de tissus et de membranes biologiques | |
US20110293691A1 (en) | Multimodal adhesion barrier | |
van Goor | MMP]. Reijnen JFGM Meis VA Postma | |
Durmus et al. | Comparison of the effects of different concentrations of sodium carboxymethylcellulose on prevention of intraabdominal adhesions in rats | |
Akçıl et al. | Composing an Adhesion Barrier Using Hyaluronic Acid and Carboxymethylcellulose to Prevent Mediastinal Adhesion | |
Sikkink et al. | Hyaluronan-based antiadhesive agents in abdominal surgery: applications, results, and mechanisms of action | |
Goldberg | Tissue-protective solutions and films for adhesion prevention | |
US5589169A (en) | Method and therapeutic compositions for the prevention of fibrin deposition or adhesions | |
Reijnen et al. | Hyaluronan-based agents do not affect anastomotic strength in the rat colon, in either the | |
KR101349200B1 (ko) | 헥소사민 화합물 또는 이의 약학적으로 허용 가능한 염을포함하는, 수술 후 유착의 예방 또는 치료용 약학 조성물 | |
Burns et al. | Hyaluronan-Based Membrane for the Prevention of Postsurgical Adhesions | |
Sikkink et al. | Applications, Results, and Mechanisms of Action |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FZDE | Dead |